Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
9 | 21971153 | missense variant | T/C | snv | 9.5E-06 | 2.8E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 12 | 1998 | 2015 | ||||||||
|
9 | 21971108 | missense variant | T/G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 10 | 1998 | 2014 | ||||||||||
|
9 | 21971037 | missense variant | C/A;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 4 | 1998 | 2011 | ||||||||||
|
9 | 21971209 | splice acceptor variant | C/A;G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 4 | 2001 | 2016 | ||||||||||
|
9 | 21971156 | missense variant | G/A;C | snv | 4.7E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 3 | 1996 | 2011 | |||||||||
|
9 | 21974696 | stop gained | G/A;C | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 3 | 1998 | 2007 | ||||||||||
|
9 | 21971210 | splice acceptor variant | T/C | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 2 | 2012 | 2017 | ||||||||||
|
9 | 21986848 | intron variant | T/A | snv | 0.74 |
|
0.800 | 1.000 | 2 | 2011 | 2016 | ||||||||||
|
9 | 21990458 | intron variant | C/T | snv | 0.74 |
|
0.700 | 1.000 | 2 | 2016 | 2019 | ||||||||||
|
9 | 21971030 | stop gained | C/T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
9 | 21971116 | missense variant | G/A;C | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||||
|
9 | 21971037 | missense variant | C/A;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
9 | 21971178 | stop gained | C/A;T | snv | 4.6E-06 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
9 | 21971154 | stop gained | C/A | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
9 | 21971029 | stop gained | C/T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
9 | 21974817 | missense variant | G/C | snv | 1.3E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2001 | 2001 | |||||||||
|
9 | 21971203 | start lost | C/T | snv | 4.5E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2002 | 2002 | |||||||||
|
9 | 21971138 | missense variant | T/G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
9 | 21989331 | intron variant | T/C | snv | 2.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
9 | 21989331 | intron variant | T/C | snv | 2.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
9 | 21986848 | intron variant | T/A | snv | 0.74 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
9 | 21986848 | intron variant | T/A | snv | 0.74 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
9 | 21986848 | intron variant | T/A | snv | 0.74 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
9 | 21986848 | intron variant | T/A | snv | 0.74 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
9 | 21986848 | intron variant | T/A | snv | 0.74 |
|
0.700 | 1.000 | 1 | 2019 | 2019 |